Press Releases Are ‘Incomplete Substitutes’ For FDA Letters

FDA analysis finds few matches between ‘complete response’ letters, press releases. But few specific factors about sponsors and NDAs could clearly be shown to be predictive of disclosure.

More from Archive

More from Pink Sheet